From: ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies
Observation period
Restricted mean survival time
Rs671(−)
Rs671(+)
0–6 months
0.82
0.58
6–12 months
0.46
0.31
12–24 months
0.25
0.26
24–36 months
0.20